Galectin-9 ameliorates respiratory syncytial virus-induced pulmonary immunopathology through regulating the balance between Th17 and regulatory T cells

Virus Research

Volumn 195, Issue , 2015, Pages 162-171

  Lu, Xiaoxia ^a   McCoy, Karen S ^b   Xu, Jiali ^a   Hu, Weikun ^c   Chen, Hebin ^a   Jiang, Kun ^a   Han, Feng ^a   Chen, Peng ^a   Wang, Yanli ^a  

^a Wuhan Children's Hospital   (China)

^b THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

^c HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Galectin 9; RAAV9; Regulatory T cells; Respiratory syncytial virus; Th17 cell

Indexed keywords

ADENOVIRUS VECTOR; ECALECTIN; MEMBRANE PROTEIN; TIM 3 PROTEIN; UNCLASSIFIED DRUG; GALECTIN; GALECTIN 9, MOUSE; IMMUNOSUPPRESSIVE AGENT;

ADENOVIRUS; ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; CD8+ T LYMPHOCYTE; CELL EXPANSION; CELLULAR IMMUNITY; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GROWTH INHIBITION; HEP 2 CELL LINE; HUMAN; HUMAN CELL; IMMUNOPATHOLOGY; IN VITRO STUDY; IN VIVO STUDY; MOUSE; MUCUS; NONHUMAN; PLASMID; PROTEIN PROTEIN INTERACTION; RECEPTOR UPREGULATION; REGULATORY T LYMPHOCYTE; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; RESPIRATORY SYNCYTIAL VIRUS INFECTION; SIGNAL TRANSDUCTION; TH1 CELL; TH17 CELL; VIRAL GENE DELIVERY SYSTEM; VIRUS LOAD; VIRUS PNEUMONIA; VIRUS RECOMBINANT; VIRUS STRAIN; ADENOVIRIDAE; ANIMAL; BAGG ALBINO MOUSE; DRUG EFFECTS; GENE VECTOR; GENETICS; HUMAN RESPIRATORY SYNCYTIAL VIRUS; IMMUNOLOGY; IMMUNOTHERAPY; LUNG; METABOLISM; PATHOLOGY; PROCEDURES; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; VIROLOGY;

MUS; RESPIRATORY SYNCYTIAL VIRUS; RICE STRIPE VIRUS;

ADENOVIRIDAE; ANIMALS; FEMALE; GALECTINS; GENETIC VECTORS; IMMUNOSUPPRESSIVE AGENTS; IMMUNOTHERAPY; LUNG; MICE, INBRED BALB C; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RESPIRATORY SYNCYTIAL VIRUSES; T-LYMPHOCYTES, REGULATORY; TH17 CELLS; VIRAL LOAD;

EID: 84919359572     PISSN: 01681702     EISSN: 18727492     Source Type: Journal    
DOI: 10.1016/j.virusres.2014.10.011     Document Type: Article

References (38)

1. Auricchio A., Hildinger M., O'Connor E., Gao G.P., Wilson J.M. Isolation of highly infectious and pure adeno-associated virus type 2 vectors with a single-step gravity-flow column. Hum. Gene. Ther. 2001, 12:71-76.
2. Bell C.L., Gurda B.L., Van Vliet K., Agbandje-McKenna M., Wilson J.M. Identification of the galactose binding domain of the adeno-associated virus serotype 9 capsid. J. Virol. 2012, 86:7326-7333.
3. Bystrom J., Al-Adhoubi N., Al-Bogami M., Jawad A.S., Mageed R.A. Th17 lymphocytes in respiratory syncytial virus infection. Viruses 2013, 5:777-791.
4. Cannon M.J., Openshaw P.J., Askonas B.A. Cytotoxic T cells clear virus but augment lung pathology in mice infected with respiratory syncytial virus. J. Exp. Med. 1988, 168:1163-1168.
5. Cimolai N., Taylor G.P., Mah D., Morrison B.J. Definition and application of a histopathological scoring scheme for an animal model of acute Mycoplasma pneumoniae pulmonary infection. Microbiol. Immunol. 1992, 36:465-478.
6. Durant L.R., Makris S., Voorburg C.M., Loebbermann J., Johansson C., Openshaw P.J. Regulatory T cells prevent Th2 immune responses and pulmonary eosinophilia during respiratory syncytial virus infection in mice. J. Virol. 2013, 87:10946-10954.
7. Gualdi L., Mertz S., Gomez A.M., Ramilo O., Wittke A., Mejias A. Lack of effect of bovine lactoferrin in respiratory syncytial virus replication and clinical disease severity in the mouse model. Antiviral Res. 2013, 99:188-195.
8. Faber T.E., Groen H., Welfing M., Jansen K.J., Bont L.J. Specific increase in local IL-17 production during recovery from primary RSV bronchiolitis. J. Med. Virol. 2012, 84:1084-1088.
9. Fulton R.B., Meyerholz D.K., Varga S.M. Foxp3+ CD4 regulatory T cells limit pulmonary immunopathology by modulating the CD8T cell response during respiratory syncytial virus infection. J. Immunol. 2010, 15:2382-2392.
10. Hashimoto K., Durbin J.E., Zhou W., Collins R.D., Ho S.B., Kolls J.K., Dubin P.J., Sheller J.R., Goleniewska K., O'Neal J.F., Olson S.J., Mitchell D., Graham B.S., Peebles R.S. Respiratory syncytial virus infection in the absence of STAT 1 results in airway dysfunction, airway mucus, and augmented IL-17 levels. J. Allergy Clin. Immunol. 2005, 116:550-557.
11. Hou W., Kang H.S., Kim B.S. Th17 cells enhance viral persistence and inhibit T cell cytotoxicity in a model of chronic virus infection. J. Exp. Med. 2009, 206:313-328.
12. Kallal L.E., Hartigan A.J., Hogaboam C.M., Schaller M.A., Lukacs N.W. Inefficient lymph node sensitization during respiratory viral infection promotes IL-17-mediated lung pathology. J. Immunol. 2010, 185:4137-4147.
13. Jafri H.S., Chavez-Bueno S., Mejias A., Gomez A.M., Rios A.M., Nassi S.S., Yusuf M., Kapur P., Hardy R.D., Hatfield J., Rogers B.B., Krisher K., Ramilo O. Respiratory syncytial virus induces pneumonia, cytokine response, airway obstruction, and chronic inflammatory infiltrates associated with long-term airway hyperresponsiveness in mice. J. Infect. Dis. 2004, 189:1856-1865.
14. Larrañaga C.L., Ampuero S.L., Luchsinger V.F., Carrión F.A., Aguilar N.V., Morales P.R., Palomino M.A., Tapia L.F., Avendaño L.F. Impaired immune response in severe human lower tract respiratory infection by respiratory syncytial virus. Pediatr. Infect. Dis. J. 2009, 28:867-873.
15. Legg J.P., Hussain I.R., Warner J.A., Johnston S.L., Warner J.O. Type 1 and type 2 cytokine imbalance in acute respiratory syncytial virus bronchiolitis. Am. J. Respir. Crit. Care Med. 2003, 168:633-639.
16. Limberis M.P., Wilson J.M. Adeno-associated virus serotype 9 vectors transduce murine alveolar and nasal epithelia and can be readministered. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:12993-12998.
17. Liu J., Ruckwardt T.J., Chen M., Johnson T.R., Graham B.S. Characterization of respiratory syncytial virus M- and M2-specific CD4T cells in a murine model. J. Virol. 2009, 83:4934-4941.
18. Loebbermann J., Thornton H., Durant L., Sparwasser T., Webster K.E., Sprent J., Culley F.J., Johansson C., Openshaw P.J. Regulatory T cells expressing granzyme B play a critical role in controlling lung inflammation during acute viral infection. Mucosal Immunol. 2012, 5:161-172.
19. Lotz M.T., Peebles R.S. Mechanisms of respiratory syncytial virus modulation of airway immune responses. Curr. Allergy Asthma Rep. 2012, 12:380-387.
20. Oomizu S., Arikawa T., Niki T., Kadowaki T., Ueno M., Nishi N., Yamauchi A., Hattori T., Masaki T., Hirashima M. Cell surface galectin-9 expressing Th cells regulate Th17 and Foxp3+ Treg development by galectin-9 secretion. PLoS One 2012, 7:e48574.
21. Openshaw P.J., Chiu C. Protective and dysregulated T cell immunity in RSV infection. Curr. Opin. Virol. 2013, 3:468-474.
22. Jonathan P.Moorman, Jia M.Wang, Ying Zhang, Xiao J.Ji, Cheng J.Ma, Xiao Y.Wu, Zhan S.Jia, Ke S.Wang, Zhi Q.Yao Tim-3 pathway controls regulatory and effector T cell balance during HCV infection. J. Immunol. 2012, 15:755-766.
23. Jones R.B., Lishomwa C. Ndhlovu, Jason D. Barbour, Prameet M. Sheth, Aashish R. Jha, Brian R. Long, Jessica C. Wong, Malathy Satkunarajah, Marc Schweneker, Joan M. Chapman, Gabor Gyenes, Bahareh Vali, Martin D. Hyrcza, Feng Yun Yue, Colin Kovacs, Aref Sassi, Mona Loutfy, Roberta Halpenny, Desmond Persad, Gerald Spotts, Frederick M. Hecht, Tae-Wook Chun, Joseph M. McCune, Rupert Kaul, James M. Rini, Douglas F. Nixon, Mario A. Ostrowski, 2008. Tim-3 expression defines a novel population of dysfunctional T cells withhighly elevated frequencies in progressive HIV-1 infection. J. Exp. Med. 205, 2763-2779.
24. McKimm-Breschkin J.L. A simplified plaque assay for respiratory syncytial virus-direct visualization of plaques without immunostaining. J. Virol. Methods 2004, 120:113-117.
25. Murphy K.M., Reiner S.L. The lineage decisions of helper T cells. Nat. Rev. Immunol. 2002, 2:933-944.
26. Mukherjee S., Lindell D.M., Berlin A.A., Morris S.B., Shanley T.P., Hershenson M.B., Lukacs N.W. IL-17-induced pulmonary pathogenesis during respiratory viral infection and exacerbation of allergic disease. Am. J. Pathol. 2011, 179:248-258.
27. Nair H., Nokes D.J., Gessner B.D., Dherani M., Madhi S.A., Singleton R.J., O'Brien K.L., Roca A., Wright P.F., Bruce N., Chandran A., Theodoratou E., Sutanto A., Sedyaningsih E.R., Ngama M., Munywoki P.K., Kartasasmita C., Simões E.A., Rudan I., Weber M.W., Campbell H. Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis. Lancet 2010, 375:1545-1555.
28. Nieto K., Stahl-Hennig C., Leuchs B., Müller M., Gissmann L., Kleinschmidt J.A. Intranasal vaccination with AAV5 and 9 vectors against human papillomavirus type 16 in rhesus macaques. Hum. Gene Ther. 2012, 23:733-741.
29. Niwa H., Satoh T., Matsushima Y., Hosoya K., Saeki K., Niki T., Hirashima M., Yokozeki H. Stable form of galectin-9, a Tim-3 ligand, inhibits contact hypersensitivity and psoriatic reactions: a potent therapeutic tool for Th1- and/or Th17-mediated skin inflammation. Clin. Immunol. 2009, 132:184-194.
30. Numasaki M., Fukushi J., Ono M., Narula S.K., Zavodny P.J., Kudo T., Robbins P.D., Tahara H., Lotze M.T. Interleukin-17 promotes angiogenesis and tumor growth. Blood 2003, 101:2620-2627.
31. Paes B.A., Mitchell I., Banerji A., LanctÔt K.L., Langley J.M. A decade of respiratory syncytial virus epidemiology and prophylaxis: translating evidence into everyday clinical practice. Can. Respir. J. 2011, 18:e10-e19.
32. Sehrawat S., Suryawanshi A., Hirashima M., Rouse B.T. Role of Tim-3/galectin-9 inhibitory interaction in viral-induced immunopathology: shifting the balance toward regulators. J. Immunol. 2009, 182:3191-3201.
33. Seki M., Oomizu S., Sakata K.M., Sakata A., Arikawa T., Watanabe K., Ito K., Takeshita K., Niki T., Saita N., Nishi N., Yamauchi A., Katoh S., Matsukawa A., Kuchroo V., Hirashima M. Galectin-9 suppresses the generation of Th17, promotes the induction of regulatory T cells, and regulates experimental autoimmune arthritis. Clin. Immunol. 2008, 127:78-88.
34. Sigurs N., Gustafsson P.M., Bjarnason R., Lundberg F., Schmidt S., Sigurbergsson F., Kjellman B. Severe respiratory syncytial virus bronchiolitis in infancy and asthma and allergy at age 13. Am. J. Respir. Crit. Care Med. 2005, 171:137-141.
35. Stilwell J.L., Samulski R.J. Adeno-associated virus vectors for therapeutic gene transfer. Biotechniques 2003, 34:148-150.
36. Zhou L., Chong M.M., Littman D.R. Plasticity of CD4+ T cell lineage differentiation. Immunity 2009, 30:646-655.
37. Zhou L., Lopes J.E., Chong M.M., Ivanov I.I., Min R., Victora G.D., Shen Y., Du J., Rubtsov Y.P., Rudensky A.Y., Ziegler S.F., Littman D.R. TGF-beta-induced Foxp3 inhibits T(H)17 cell differentiation by antagonizing ROR gammat function. Nature 2008, 453:236-240.
38. Zhu C., Anderson A.C., Schubart A., Xiong H., Imitola J., Khoury S.J., Zheng X.X., Strom T.B., Kuchroo V.K. The Tim-3 ligand galectin-9 negatively regulates T helper type 1 immunity. Nat. Immunol. 2005, 6:1245-1252.